ALARIS Medical Systems Wins Medical Design Excellence Award.Business Editors/Health/Medical Writers Medical Design & Manufacturing Conference and Exposition SAN DIEGO--(BUSINESS WIRE)--June 4, 2003 SmartSite(R) Plus Needle-Free Valve Awarded Gold Level for Its Unique Design That Enhances the Safety of Patients and Caregivers ALARIS Medical Systems Inc., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of ALARIS Medical Inc. (AMEX AMEX See: American Stock Exchange :AMI), announced today that its SmartSite(R) Plus Needle-Free Valve has won the Gold Medical Design Excellence Award (MDEA MDEA 3,4-Methylenedioxy-N-Ethylamphetamine (empathogenic/psychedelic drug closely related to MDMA) MDEA Master Data Exchange Agreement MDEA Methyl Di-Ethyl Amine ). The Gold Award was announced yesterday during the Medical Design & Manufacturing Conference and Exposition at the Jacob K. Javits Convention Center Jacob K. Javits Convention Center is a large convention center on the west side of Manhattan in New York City. It was designed by architects I. M. Pei and partners. The revolutionary space frame structure was built in 1986 and named for New York Senator Jacob K. in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The SmartSite(R) Plus Needle-Free Valve, released in 2002, is the latest addition to the ALARIS(R) SmartSite(R) Needle-Free System line of products. The SmartSite(R) Plus Needle-Free Valve is designed to enhance the safety of patients and caregivers by providing passive, needle-free access to intravenous (IV) systems, thereby helping to reduce the danger of accidental needlesticks. The positive bolus bolus /bo·lus/ (bo´lus) 1. a rounded mass of food or pharmaceutical preparation ready to swallow, or such a mass passing through the gastrointestinal tract. 2. a concentrated mass of pharmaceutical preparation, e. feature of the SmartSite(R) Plus Valve helps clear catheter lumens and prevent retrograde flow, which thereby can help reduce the risk of clotting that can occur in catheters, which is a common problem for patients. Blood backflow backflow /back·flow/ (-flo) reflux or regurgitation (1). pyelovenous backflow drainage from the renal pelvis into the venous system occurring under certain conditions of back pressure. can allow blood to clot in the catheter, possibly necessitating the insertion of a new catheter. The SmartSite(R) Plus Valve's design helps minimize this problem, while at the same time providing a low priming volume and high flow rate for improved medication and fluid administration. "We are honored to be recognized by the MDEA judges," said Jake St. Philip, vice president and general manager of ALARIS Medical Systems' North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. Business Unit. "Understanding users' needs for a system that helps improve patient safety and comfort was vital to creating a successful design," he continued. "The SmartSite(R) Plus Valve also incorporates all of the features that made our proprietary SmartSite(R) Needle-Free Valve a market leader." This new technology is small in size, yet provides patient comfort, a straight flow-through path, and a safe and easy-to-swab design. By reducing the need for caps, cannulas and add-on components, it is more cost-effective than other needle-free systems. The SmartSite(R) Plus Needle-Free Valve is currently used in all professional health care environments including hospitals, home health care, critical care and emergency medicine for the delivery of fluids, medications, blood and blood products. The SmartSite(R) Plus Needle-Free Valve allows health care institutions to comply with the "Needlestick Safety and Prevention Act," signed into United States Law in November 2000, and meets all Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ), Occupational Safety and Health Administration Occupational Safety and Health Administration (OSHA), U.S. agency established (1970) in the Dept. of Labor (see Labor, United States Department of) to develop and enforce regulations for the safety and health of workers in businesses that are engaged in interstate (OSHA OSHA n. Occupational Safety and Health Administration, a branch of the US Department of Labor responsible for establishing and enforcing safety and health standards in the workplace. ) and Joint Commission on Accreditation of Healthcare Organizations Joint Commission on Accreditation of Healthcare Organizations, n.pr the United States body that accredits healthcare organizations. Joint Commission on Accreditation of Healthcare Organizations (JCAHO/TJC), n. (JCAHO JCAHO Joint Commission on Accreditation of Healthcare Organizations, see there ) requirements. Many companies added needle-free access valves to their product lines to meet health care institutions' needs after the "Needlestick Safety and Prevention Act." However, ALARIS Medical Systems' product is the only one to combine several essential capabilities: having few components, a simple snap-together design, non-tortuous fluid path and positive displacement to help reduce the risk of clotting in catheters. ALARIS Medical Systems introduced its SmartSite(R) Needle-Free line of products in 1996 and won the MDEA Gold Award in 1998. About the Medical Design Excellence Awards The MDEA competition is sponsored by Canon Communications LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and is the only awards program that exclusively recognizes contributions and advances in the design of medical products. Entries are evaluated on design and engineering features including innovative use of materials, user-related functions that improve health care deliver and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so the product meets its clinical objectives. A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering Biomedical engineering An interdisciplinary field in which the principles, laws, and techniques of engineering, physics, chemistry, and other physical sciences are applied to facilitate progress in medicine, biology, and other life sciences. , human factors, industrial design, medicine, and diagnostics. About ALARIS Medical Inc. ALARIS Medical Inc., through its wholly owned operating company, ALARIS Medical Systems Inc., develops practical solutions for medication safety. The company designs, manufactures and markets intravenous (IV) medication delivery and infusion therapy devices, needle-free disposables and related monitoring equipment in the United States and internationally. ALARIS Medical's proprietary Guardrails(R) Safety Software, its other "smart" technologies and its "smart" services help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and also gather and record clinical information for review, analysis and transcription. The company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors. With headquarters in San Diego, ALARIS Medical employs approximately 2,900 people worldwide. Additional information on ALARIS Medical can be found at http://www.alarismed.com. This news release contains forward-looking statements as defined in the Safe Harbor Provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Persons reading this release are cautioned that such forward-looking statements involve risks and uncertainties, including the effect of legislative and regulatory changes affecting the health care industry, the potential of increased levels of competition, technological changes, the dependence of ALARIS Medical upon the success of new products (including its proprietary Guardrails(R) Safety Software and the Medley(TM) Medication Safety System) and ongoing research and development efforts including obtaining regulatory approvals, restrictions contained in the instruments governing the company's indebtedness, and the significant leverage to which the company is subject. Such risk factors are detailed in the Securities and Exchange Commission filings of ALARIS Medical Inc. and ALARIS Medical Systems Inc., including Forms 10-K for the year ended Dec. 31, 2002, and other filings. The company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion